HR

Harinder Ramraj Kanojia

Active Director Director DIN 10709116
DIN 10709116 First appointment Jul 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Harinder Ramraj Kanojia

Data last updated:

Harinder Ramraj Kanojia is a Director at Meditota Health Care Private Limited (since 2024). The company operates in Pharma.

DIN 10709116
Primary Designation Director
Industry Pharma
First Appointment 17 Jul 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Meditota Health Care Private Limited U47721MH2024PTC428943
Director17 Jul 20242024Active

Board colleagues of Harinder Ramraj Kanojia

NameDINCompanyDesignation
Savari Munesh Pal10709115Meditota Health Care Private LimitedDirector

Directorship timeline

Open interactive timeline →
Meditota Health Care Private Limited
Premium access

Shareholding and investment profile for Harinder Ramraj Kanojia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Harinder Ramraj Kanojia

Harinder Ramraj Kanojia currently holds 1 directorship: Meditota Health Care Private Limited (Director, since 17 Jul 2024).

Harinder Ramraj Kanojia was first appointed on 17 Jul 2024 as Director at Meditota Health Care Private Limited.

The current boards of Harinder Ramraj Kanojia's companies include Savari Munesh Pal (Meditota Health Care Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available